101
|
Islam MA, Bekele R, Vanden Berg JHJ, Kuswanti Y, Thapa O, Soltani S, van Leeuwen FXR, Rietjens IMCM, Murk AJ. Deconjugation of soy isoflavone glucuronides needed for estrogenic activity. Toxicol In Vitro 2015; 29:706-15. [PMID: 25661160 DOI: 10.1016/j.tiv.2015.01.013] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2014] [Revised: 01/17/2015] [Accepted: 01/26/2015] [Indexed: 10/24/2022]
Abstract
Soy isoflavones (SIF) are present in the systemic circulation as conjugated forms of which the estrogenic potency is not yet clear. The present study provides evidence that the major SIF glucuronide metabolites in blood, genistein-7-O-glucuronide (GG) and daidzein-7-O-glucuronide (DG), only become estrogenic after deconjugation. The estrogenic potencies of genistein (Ge), daidzein (Da), GG and DG were determined using stably transfected U2OS-ERα, U2OS-ERβ reporter gene cells and proliferation was tested in T47D-ERβ cells mimicking the ERα/ERβ ratio of healthy breast cells and inT47D breast cancer cells. In all assays applied, the estrogenic potency of the aglycones was significantly higher than that of their corresponding glucuronides. UPLC analysis revealed that in U2OS and T47D cells, 0.2-1.6% of the glucuronides were deconjugated to their corresponding aglycones. The resulting aglycone concentrations can account for the estrogenicity observed upon glucuronide exposure. Interestingly, under similar experimental conditions, rat breast tissue S9 fraction was about 30 times more potent in deconjugating these glucuronides than human breast tissue S9 fraction. Our study confirms that SIF glucuronides are not estrogenic as such, and that the small % of deconjugation in the cell is enough to explain the slight bioactivity observed for the SIF-glucuronides. Species differences in deconjugation capacity should be taken into account when basing risk-benefit assessment of these SIF for the human population on animal data.
Collapse
Affiliation(s)
- M A Islam
- Division of Toxicology, Wageningen University, 6703 HE Wageningen, The Netherlands.
| | - R Bekele
- Division of Toxicology, Wageningen University, 6703 HE Wageningen, The Netherlands
| | - J H J Vanden Berg
- Division of Toxicology, Wageningen University, 6703 HE Wageningen, The Netherlands
| | - Y Kuswanti
- Division of Toxicology, Wageningen University, 6703 HE Wageningen, The Netherlands
| | - O Thapa
- Division of Toxicology, Wageningen University, 6703 HE Wageningen, The Netherlands
| | - S Soltani
- Division of Toxicology, Wageningen University, 6703 HE Wageningen, The Netherlands
| | - F X R van Leeuwen
- Division of Toxicology, Wageningen University, 6703 HE Wageningen, The Netherlands
| | - I M C M Rietjens
- Division of Toxicology, Wageningen University, 6703 HE Wageningen, The Netherlands
| | - A J Murk
- Division of Toxicology, Wageningen University, 6703 HE Wageningen, The Netherlands
| |
Collapse
|
102
|
Affiliation(s)
- Sepideh Soltani
- Department of Physics and Astronomy, The University of Western Ontario, London, Ontario N6A 3K7, Canada
| | - Myong In Oh
- Department of Chemistry, The University of Western Ontario, London, Ontario N6A 5B7, Canada
| | - Styliani Consta
- Department of Physics and Astronomy, The University of Western Ontario, London, Ontario N6A 3K7, Canada
- Department of Chemistry, The University of Western Ontario, London, Ontario N6A 5B7, Canada
| |
Collapse
|
103
|
Nemati S, Amirzargar AA, Farhadi E, Hirbod-Mobarakeh A, Nabavi M, Soltani S, Mahdaviani SA, Shahinpour S, Arshi S, MirAhmadian M, Nicknam MH, Aghamohammadi A, Rezaei N. RAD50 Single-Nucleotide Polymorphism in Predominantly Antibody Deficiency. J Investig Allergol Clin Immunol 2015; 25:299-301. [PMID: 26310047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023] Open
|
104
|
Tavakol M, Amirzargar A, Movahedi M, Aryan Z, Bidoki A, Gharagozlou M, Aghamohammadi A, Nabavi M, Ahmadvand A, Behniafard N, Heidari K, Soltani S, Rezaei N. Interleukin-6 and tumor necrosis factor-alpha gene polymorphisms in chronic idiopathic urticaria. Allergol Immunopathol (Madr) 2014; 42:533-8. [PMID: 24051251 DOI: 10.1016/j.aller.2013.06.004] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2013] [Revised: 06/04/2013] [Accepted: 06/10/2013] [Indexed: 12/20/2022]
Abstract
BACKGROUND This study was performed to evaluate association of gene polymorphisms among proinflammatory cytokines and susceptibility to chronic idiopathic urticaria (CIU). METHODS Ninety patients with prolonged urticaria more than 6 weeks were included as case group. Single nucleotide polymorphisms (SNPs) of IL-6 (G/C -174, G/A nt565) and TNF-α (G/A -308, G/A -238) were evaluated, using polymerase chain reaction (PCR); and the results were compared to the control group. RESULTS G allele was significantly higher in the patients at locus of -238 of promoter of TNF-α gene (p<0.001). Frequency of following genotypes were significantly lower in patients with CIU, compared to controls: AG at -308 and GA at -238 of TNF-α gene (p<0.05 and p<0.001, respectively), CG at -174 and GG at +565 of IL-6 gene (p<0.05). Additionally, following genotypes were more common among patients with CIU: GG at -308 and -238 of TNF-α gene (p<0.05 and p<0.001, respectively), GG at -174 and GA at +565 of IL-6 gene (p<0.05). CONCLUSIONS Pro-inflammatory cytokine gene polymorphisms can affect susceptibility to CIU. TNF-α promoter polymorphisms as well as IL-6 gene polymorphisms are associated with CIU.
Collapse
|
105
|
Mahmoudi M, Tahghighi F, Ziaee V, Harsini S, Rezaei A, Soltani S, Sadr M, Moradinejad MH, Aghighi Y, Rezaei N. Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet 2014; 41:512-7. [DOI: 10.1111/iji.12152] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2014] [Revised: 08/28/2014] [Accepted: 09/07/2014] [Indexed: 11/28/2022]
Affiliation(s)
- M. Mahmoudi
- School of Nutrition and Dietetics; Tehran University of Medical Sciences; Tehran Iran
| | - F. Tahghighi
- Pediatric Rheumatology Research Group; Rheumatology Research Center; Tehran University of Medical Sciences; Tehran Iran
- Pediatrics Center of Excellence; Children's Medical Center; Tehran University of Medical Sciences; Tehran Iran
| | - V. Ziaee
- Pediatric Rheumatology Research Group; Rheumatology Research Center; Tehran University of Medical Sciences; Tehran Iran
- Pediatrics Center of Excellence; Children's Medical Center; Tehran University of Medical Sciences; Tehran Iran
| | - S. Harsini
- Research Center for Immunodeficiencies; Children's Medical Center; Tehran University of Medical Sciences; Tehran Iran
| | - A. Rezaei
- Research Center for Immunodeficiencies; Children's Medical Center; Tehran University of Medical Sciences; Tehran Iran
| | - S. Soltani
- Molecular Immunology Research Center; Tehran University of Medical Sciences; Tehran Iran
- Department of Immunology; School of Medicine; Tehran University of Medical Sciences; Tehran Iran
| | - M. Sadr
- Molecular Immunology Research Center; Tehran University of Medical Sciences; Tehran Iran
- Department of Immunology; School of Medicine; Tehran University of Medical Sciences; Tehran Iran
| | - M. H. Moradinejad
- Pediatrics Center of Excellence; Children's Medical Center; Tehran University of Medical Sciences; Tehran Iran
| | - Y. Aghighi
- Department of Pediatrics; Imam Khomeini Hospital; Tehran University of Medical Sciences; Tehran Iran
| | - N. Rezaei
- Pediatrics Center of Excellence; Children's Medical Center; Tehran University of Medical Sciences; Tehran Iran
- Research Center for Immunodeficiencies; Children's Medical Center; Tehran University of Medical Sciences; Tehran Iran
- Molecular Immunology Research Center; Tehran University of Medical Sciences; Tehran Iran
- Department of Immunology; School of Medicine; Tehran University of Medical Sciences; Tehran Iran
| |
Collapse
|
106
|
Farhadi E, Nemati S, Amirzargar AA, Hirbod-Mobarakeh A, Nabavi M, Soltani S, Mahdaviani SA, Shahinpour S, Arshi S, Nikbin B, Aghamohammadi A, Rezaei N. AICDA single nucleotide polymorphism in common variable immunodeficiency and selective IgA deficiency. Allergol Immunopathol (Madr) 2014; 42:422-6. [PMID: 23731676 DOI: 10.1016/j.aller.2013.02.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2013] [Revised: 02/21/2013] [Accepted: 02/26/2013] [Indexed: 11/16/2022]
Abstract
BACKGROUND Primary antibody deficiencies (PADs) are a heterogeneous group of disorders, characterised by increased susceptibility to recurrent bacterial infections. Common variable immunodeficiency (CVID) is the most important PAD from the clinical point of view and selective IgA deficiency (IgAD) is the most common PAD. However, the underlying gene defect in both is still unknown. As a recent study in Europe showed an association between a single nucleotide polymorphism (SNP) of AICDA gene with PADs, this study was performed to evaluate such an association in Iranian patients. METHODS Fifty-eight patients with PAD, including 39 CVID and 19 IgAD, as well as 34 healthy volunteers, were enrolled in this study. Genotyping was done in all groups for an intronic SNP in AICDA (rs2580874), using real-time PCR genotyping assay. RESULTS The less frequent genotype of AICDA in IgAD patients was AA, seen in 10.5% of the patients, which was much lower than the 30.8% in CVID patients and 38.2% in the controls. However, these differences were not significant. Indeed the GG genotype in the patients with PADs was seen in 20.7%, compared to 8.8% in the controls without any significant difference. CONCLUSIONS There was no significant association between the previously reported genetic variant of AICDA gene and the development of CVID or IgAD, but further multi-center studies are also needed.
Collapse
Affiliation(s)
- E Farhadi
- Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran; Hematology Department, School of Allied Medical Science, Tehran University of Medical Sciences, Tehran, Iran
| | - S Nemati
- Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - A A Amirzargar
- Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - A Hirbod-Mobarakeh
- Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - M Nabavi
- Department of Allergy and Immunology, Rasool-e-Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - S Soltani
- Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - S A Mahdaviani
- Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - S Shahinpour
- Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
| | - S Arshi
- Department of Allergy and Immunology, Rasool-e-Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran
| | - B Nikbin
- Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - A Aghamohammadi
- Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
| | - N Rezaei
- Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
| |
Collapse
|
107
|
Loganathan G, Graham M, Spizzo T, Tiwari M, Lockridge A, Soltani S, Wilhelm J, Balamurugan A, Hering B. Pretreatment of Donor Pigs With a Diet Rich in Soybean Oil Increases the Yield of Isolated Islets. Transplant Proc 2014; 46:1945-9. [DOI: 10.1016/j.transproceed.2014.05.078] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
108
|
Azizli MJ, Naderi G, Bakhshandeh GR, Soltani S, Askari F, Esmizadeh E. IMPROVEMENT IN PHYSICAL AND MECHANICAL PROPERTIES OF IIR/CR RUBBER BLEND ORGANOCLAY NANOCOMPOSITES. Rubber Chemistry and Technology 2014. [DOI: 10.5254/rct.13.87951] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
ABSTRACT
The effects of organoclay loading and chloroprene rubber (CR) concentration on the cure characteristics, microstructure, and mechanical and rheological properties of isobutylene–isoprene rubber (IIR)/CR blend were investigated. Different compositions of CR (10, 20, and 40 wt%) with Cloisite15A as organo modified nanoclay (1, 3, 5, and 7 wt%) were used for blends by a two-roll mill. Samples were vulcanized at 175 °C using a hot press. The cure and scorch times and also the maximum torque of the composites increased with the incorporation of organoclay. Mechanical properties such as tensile strength, elongation at break, modulus (100%, 200%, and 300%), and resilience improved with increasing nanoclay loading. The structure of the nanocomposites was characterized with X-ray diffraction (XRD), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). XRD results of nanocomposites indicated that the intercalation of polymer chains into the clay gallery was deduced from increasing the interlayer distance of silicate layers. TEM and SEM also directly confirmed XRD results.
Collapse
Affiliation(s)
- M. J. Azizli
- Islamic Azad university, South Tehran Branch, Tehran, Iran
| | - G. Naderi
- Iran Polymer and Petrochemical Institute, P.O. Box 14965-115, Tehran, Iran
| | - G. R. Bakhshandeh
- Iran Polymer and Petrochemical Institute, P.O. Box 14965-115, Tehran, Iran
| | - S. Soltani
- Iran Polymer and Petrochemical Institute, P.O. Box 14965-115, Tehran, Iran
| | - F. Askari
- Iran Polymer and Petrochemical Institute, P.O. Box 14965-115, Tehran, Iran
| | - E. Esmizadeh
- Iran Polymer and Petrochemical Institute, P.O. Box 14965-115, Tehran, Iran
| |
Collapse
|
109
|
Soltani S, Kaufmann F, Vierecke J, Kretzschmar A, Henning E, Stein J, Krabatsch T, Hetzer R, Potapov E. Cable design improvements and sintering of the inflow cannula in continuous flow LVADs reduce the occurrence of life-threatening pump stops. Thorac Cardiovasc Surg 2014. [DOI: 10.1055/s-0034-1367240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
110
|
Heidarpour M, Soltani S, Mohri M, Khoshnegah J. Canine visceral leishmaniasis: relationships between oxidative stress, liver and kidney variables, trace elements, and clinical status. Parasitol Res 2012; 111:1491-6. [PMID: 22669694 DOI: 10.1007/s00436-012-2985-8] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2012] [Accepted: 05/22/2012] [Indexed: 11/28/2022]
Abstract
The aim of this study was to investigate the role of oxidative stress in the pathology of canine visceral leishmaniasis (CVL). We therefore studied the relationships between oxidative stress markers, liver and kidney variables, trace elements, and clinical status in dogs naturally infected with Leishmania infantum. Two groups of Leishmania-infected dogs [asymptomatic (AD, n = 14) and symptomatic (SD, n = 16)] were assessed and compared with a group of non-infected control dogs (CD, n = 30). A significant decrease (p < 0.001) in serum total antioxidant status (TAS) and albumin concentration (p < 0.05) and a significant increase in serum malondialdehyde (MDA) and blood urea nitrogen (BUN) concentrations (p < 0.001), in the SD group, were observed when compared to CD and AD groups. Dogs of the AD group presented a significant decrease in copper (p < 0.01) and zinc (p < 0.001) concentrations, when compared to CD group, while the SD group presented a significant decrease (p < 0.001) in copper and zinc concentrations, when compared to CD and AD groups. Oxidative stress markers (MDA and TAS) showed significant correlations (p < 0.001) with trace elements (copper and zinc) and liver (alanine aminotransferase) and kidney (BUN and creatinine) variables. The results of the present study revealed that symptomatic dogs showed more severe oxidative stress than asymptomatic and non-infected dogs and enhanced lipid peroxidation may be linked to liver and kidney damage in canine visceral leishmaniasis.
Collapse
Affiliation(s)
- M Heidarpour
- Department of Clinical Sciences, School of Veterinary Medicine, Ferdowsi University of Mashhad, PO Box 91775-1793, Mashhad, Iran.
| | | | | | | |
Collapse
|
111
|
Jouyban A, Soltanpour S, Soltani S, Tamizi E, Fakhree MA, Acree W. Prediction of drug solubility in mixed solvents using computed Abraham parameters. J Mol Liq 2009. [DOI: 10.1016/j.molliq.2009.02.003] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
112
|
Rasekhi AR, Nabavizadeh SA, Malek-Hosseini SA, Varedi P, Naderifar M, Soltani S. Percutaneous transhepatic venous angioplasty and stenting in a 9-month-old patient with hepatic vein obstruction after partial liver transplantation. Cardiovasc Intervent Radiol 2008; 31:1034-7. [PMID: 18338211 DOI: 10.1007/s00270-008-9322-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2007] [Revised: 01/31/2008] [Accepted: 02/05/2008] [Indexed: 01/10/2023]
Abstract
Hepatic venous outflow obstruction is a rare but serious complication after liver transplantation. We report ultrasound-guided percutaneous transhepatic stent placement in a 9-month-old infant with a left lateral split liver transplantation with near-complete hepatic vein obstruction.
Collapse
Affiliation(s)
- A R Rasekhi
- Imaging Research Center, Department of Radiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
| | | | | | | | | | | |
Collapse
|
113
|
Soltani S, . HB, . KAZ, . AJ. Modelling Vasorelaxant Activity of Some Drugs/Drug Candidates Using Artificial Neural Networks. ACTA ACUST UNITED AC 2007. [DOI: 10.3923/jpt.2007.411.426] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
114
|
Jouyban A, Soltanpour S, Soltani S, Chan HK, Acree WE. Solubility prediction of drugs in water-cosolvent mixtures using Abraham solvation parameters. J Pharm Pharm Sci 2007; 10:263-77. [PMID: 17727790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
Abstract
PURPOSE To provide predictive cosolvency models, the Abraham solvation parameters of solutes and the solvent coefficients were combined with the Jouyban-Acree and the log-linear models. These models require two and one solubility data points to predict the solubility of drugs in water-cosolvent mixtures. Ab initio prediction methods also were employed and the results were discussed. METHOD The Jouyban-Acree model constants were correlated with variables derived from the Abraham solvation parameters of solutes and the solvent coefficients to present quantitative structure property relationship (QSPR) models. The calculated model constants using the QSPR models were used to predict the solubility in water-cosolvent mixtures. The mean percentage deviation (MPD), average absolute error (AAE) and root mean square error (RMSE) criteria were calculated to show the accuracy of the predictions. RESULTS The overall MPD (+/-SD) of the proposed method employing solubility data in mono-solvents, i.e. two data points for each set, was 18.5+/-12.0 which indicates an acceptable prediction error from the practical point of view. The best cosolvency model employing aqueous solubility data was produced overall MPD of 75.2+/-72.6. The overall MPD of the proposed ab initio method was 74.9+/-19.3%. The models produced the same accuracy pattern considering MPD, AAE and RMSE criteria. CONCLUSION The proposed model employing two solubility data points for each set produced acceptable prediction error (>>18%) and could be recommended for practical applications in pharmaceutical industry. MPD, AAE and RMSE criteria produced similar results considering various models. However, MPD criterion was preferred since its numerical values could be compared with experimental relative standard deviations for repeated experiments.
Collapse
Affiliation(s)
- A Jouyban
- Faculty of Pharmacy and Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
| | | | | | | | | |
Collapse
|
115
|
Coleman R, Favaloro EJ, Soltani S, Keng TB. Acquired von Willebrand disease: potential contribution of the VWF:CB to the identification of functionally inhibiting auto-antibodies to von Willebrand factor. J Thromb Haemost 2006; 4:2085-8. [PMID: 16961622 DOI: 10.1111/j.1538-7836.2006.02072.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
116
|
Zeeh JM, Procaccino F, Hoffmann P, Aukerman SL, McRoberts JA, Soltani S, Pierce GF, Lakshmanan J, Lacey D, Eysselein VE. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 1996; 110:1077-83. [PMID: 8612996 DOI: 10.1053/gast.1996.v110.pm8612996] [Citation(s) in RCA: 95] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
BACKGROUND & AIMS Keratinocyte growth factor (KGF) is known to enhance tissue repair in the skin; however, its role in the gastrointestinal tract is largely unknown. The aim of this study was to evaluate the effects of exogenous KGF in an experimental model of colitis in rats. METHODS KGF was administered before or after induction of colitis with 2,4,6-trinitrobenzenesulfonic acid/ethanol. In the first two study groups, KGF (5 mg/kg) was administered intraperitoneally 24 hours and 1 hour before induction of colitis; animals were killed 8 hours (n=10) and 1 week (n=10) after injury. In subsequent study groups, KGF or vehicle treatment was begun 24 hours after the induction of colitis at doses of 5 (n=20), 1 (n=10), and 0.1 (n=10) mg/kg intraperitoneally and continued once daily for 1 week. Colonic tissue samples were evaluated macroscopically and microscopically for mucosal injury and assayed for myeloperoxidase activity. RESULTS Administration of KGF after but not before induction of colitis significantly ameliorated tissue damage. Macroscopic necrosis and microscopic ulcerations were reduced by 40%-50% at KGF doses of 1 and 5 mg/kg. CONCLUSIONS Exogenous KGF has a key role in mucosal healing in an experimental model of colitis in rats.
Collapse
Affiliation(s)
- J M Zeeh
- Inflammatory Bowel Disease Center, Division of Gastroenterology, Harbor-UCLA Medical Center, Torrance, California, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|